CHIMÄRE NEUROTOXINE

European patent · EP3452071 · In force

Register entry

Publication number
EP3452071
Application number
EP17724335
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 5, 2017
Published
Mar 13, 2019
Granted
Apr 7, 2021
Protection ends at the latest
May 4, 2037
Next annual fee due
May 31, 2027
IPC classes
A61K 38/00 (2006.01)
C07K 14/33 (2006.01)
Priority
GB 201607901 05.05.2016
PCT application
PCT/EP2017/060821 05.05.2017
PCT publication
WO2017/191315 09.11.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  5. Feb 16, 2022

    Change

    Published in Swissreg on 16.02.2022

  6. Apr 10, 2021

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 10.04.2021

  7. Apr 7, 2021

    Granted

    Published in Swissreg on 07.04.2021

Parties

Holder

IPSEN BIOPHARM LIMITED

Ipsen Biopharm Limited

Unit 9, Ash Road Wrexham Industrial Estate, Wrexham LL13 9UF, GB

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

LIU, Sai Man

Oxford OX3 0SE, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.